n-(3-pyridylmethyl)adriamycin has been researched along with Hypoxia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, L; Meng, H; Wang, S; Weng, L; Wu, Z; Xu, Y; Yuan, Z; Zheng, W | 1 |
1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and Hypoxia
Article | Year |
---|---|
Malibatol A enhances alternative activation of microglia by inhibiting phosphorylation of Mammalian Ste20-like kinase1 in OGD-BV-2 cells.
Topics: Animals; Apoptosis; Cell Line, Transformed; Dose-Response Relationship, Drug; Doxorubicin; Flow Cytometry; Gene Expression Regulation; Glucose; Hypoxia; Lectins, C-Type; Mannose Receptor; Mannose-Binding Lectins; Mice; Microglia; Phosphorylation; Protein Serine-Threonine Kinases; Receptors, Cell Surface; RNA, Messenger; Signal Transduction; Stilbenes | 2016 |